VIDIUM Solutions

Founded in January 2019, Vidium introduces a groundbreaking technology that enables the control and mastery of cellular genetic expression, accelerating and de-risking the development of innovative treatments, with already proven results in challenging health issues like cancer resistance. We revolutionize drug discovery by shifting the focus from a single molecular target to the underlying causal gene regulatory network of the cell.

We are a target discovery platform combining retro-engineering and AI applied to omics data to model and validate the key genetic relationships underlying random cell behavior, providing target ID and validation, biomarkers and mechanism of action of novel drugs.